BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.215
+0.004 (2.04%)
Mar 6, 2026, 12:08 PM EST - Market open
BioRestorative Therapies Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for BioRestorative Therapies.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for BioRestorative Therapies.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $18 | Strong Buy | Maintains | $15 → $18 | +8,279.89% | Aug 14, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +6,883.24% | Jun 12, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +6,883.24% | Aug 14, 2023 |
| Roth Capital | Roth Capital | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +6,883.24% | Dec 7, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +2,693.30% | Sep 28, 2022 |
Financial Forecast
Revenue This Year
499.80K
from 401.00K
Increased by 24.64%
Revenue Next Year
1.94M
from 499.80K
Increased by 287.76%
EPS This Year
-1.66
from -1.16
EPS Next Year
-0.77
from -1.66
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 567,000 | 2.6M | ||||
| Avg | 499,800 | 1.9M | ||||
| Low | 431,200 | 1.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 41.4% | 425.2% | ||||
| Avg | 24.6% | 287.8% | ||||
| Low | 7.5% | 154.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.71 | -0.35 | ||||
| Avg | -1.66 | -0.77 | ||||
| Low | -1.60 | -1.15 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.